Pricing Log in Create free account

Bone Biologics Corp. (BBLG) vs Altamira Therapeutics Ltd. (CYTOF)

Bone Biologics Corp. and Altamira Therapeutics Ltd. are both Biotechnology companies. Bone Biologics Corp. and Altamira Therapeutics Ltd. are of similar size ($1.1M and $1.1M). Across the 8 metrics below, Bone Biologics Corp. leads on 5 and Altamira Therapeutics Ltd. on 3.

Valuation

Metric BBLG CYTOF Biotechnology median
P/E n/m n/m 8.50
P/S n/m n/m 9.71
P/B 0.18 n/m 2.13
Price to free cash flow n/m n/m 20.82
EV/EBITDA n/m n/m 0.64
EV/Sales n/m n/m 9.21
Earnings yield (342.50%) (44,544.44%) (33.15%)
Free cash flow yield (365.78%) (9,080,722.22%) (25.50%)

Profitability

Metric BBLG CYTOF Biotechnology median
Gross margin — 0.00% 65.16%
Operating margin 0.00% 0.00% 0.00%
Net margin 0.00% 0.00% 0.00%
Free cash flow margin 0.00% 0.00% 0.00%
Return on equity (54.96%) 0.00% (56.36%)
Return on assets (50.55%) 0.00% (48.04%)
Return on invested capital 0.00% 0.00% 0.00%

Growth

Metric BBLG CYTOF Biotechnology median
Revenue growth (TTM) — — 6.02%
EPS growth (last fiscal year) 90.85% 81.52% 30.26%
Revenue growth, 5-year CAGR — — 9.41%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric BBLG CYTOF Biotechnology median
Debt to equity 0.00 0.11 0.00
Current ratio 8.67 0.11 4.72
Net debt to EBITDA 1.65 (0.27) 0.96

Dividend

Metric BBLG CYTOF Biotechnology median
Dividend yield — — 0.09%
Payout ratio — — —

Size

Metric BBLG CYTOF Biotechnology median
Market cap 1.07m 1.13m 135.18m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack